128 results
Page 3 of 7
6-K
EX-99.1
mcnxe4 gbs909xak
8 Oct 14
Live Filing
12:00am
6-K
EX-99.1
8w5ce fcui8
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
EX-99.1
8e438 5k1
8 Sep 14
Successful Completion of Phase Iii Program for Teva’s Reslizumab
12:00am
6-K
EX-99.1
l54d12z45wc9xiu1
3 Sep 14
Teva Launches Syncaretm Home Administration Support Program for Patients on Synribo® (Omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
a485mpudtaa0qqjw 2sh
3 Sep 14
Live Filing
12:00am
6-K
EX-99.1
u2uwa
2 Sep 14
Live Filing
12:00am
6-K
EX-99.1
orb5gguz44n
21 Jul 14
Live Filing
12:00am
6-K
EX-99.1
s2xfyxf0z7efvw3a4
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
03o9k
18 Jun 14
Current report (foreign)
12:00am
6-K
EX-99.1
8d7u3 qbe9gd4
3 Jun 14
Live Filing
12:00am
6-K
EX-99.1
qvzb46sk
29 Apr 14
Teva Receives European Marketing Authorization for DuoResp Spiromax® for the Treatment of Asthma and COPD
12:00am
6-K
EX-99.1
gzxiri0y33 ylhz095
3 Mar 14
The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
12:00am
6-K
EX-99.1
2cydqncl
21 Feb 14
Live Filing
12:00am
6-K
EX-99.1
hhez6ebnsvsvt85i456
4 Dec 13
Teva and Takeda Announce Development and Distribution Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
12:00am
6-K
EX-99.1
607w8y1 srb40vl19wpe
4 Dec 13
Launch of www.YouDontKnowJackAboutMS.com chronicles Jack Osbourne’s life living with RRMS
12:00am
6-K
EX-99.1
p35pfwv
27 Nov 13
Teva Announces Additional Regulatory Exclusivity for Treanda® (Bendamustine Hci) for Injection
12:00am
6-K
EX-99.1
xxc8e 488pf2gseq7ut
18 Nov 13
Teva Announces Updates to Oncology Biologic Portfolio
12:00am
6-K
i4oto mym
31 Oct 13
Current report (foreign)
12:00am
6-K
EX-99.1
90dbg 4r7707rougy
1 Oct 13
Teva Announces Launch of Generic Zemplar® In the United States
12:00am